4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-017527
Chief Scientific Officer sold 9,518 shares at an average $38.70 ($368,329)
From the SEC's structured data for this filing
Trades in this filing
Leen Ann M. · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-01 | Sale : show line 1 in the form | −6,359 | $38.46 | $244,572 | 2,465,326 | I |
| 2021-03-01 | Sale : show line 2 in the form | −3,159 | $39.18 | $123,758 | 2,462,167 | I |
| Open-market sales · 9,518 sh · avg $38.70 · $368,329 | ||||||
Loading xslF345X03/doc4.xml…